Disclosure Of First-Time Adoption [Text Block]

Egetis Therapeutics - Filing #701621

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
745 792 SEK
1 305 SEK
1 262 837 SEK
527 039 SEK
8 688 SEK
641 250 SEK
1 262 837 SEK
8 688 SEK
448,000 SEK
630 723 SEK
SEK
705 278 SEK
244 876 SEK
463 220 SEK
2 818 SEK
Comprehensive income
SEK
SEK
SEK
104 542 SEK
104 542 SEK
178 024 SEK
178 024 SEK
SEK
SEK
SEK
Profit (loss)
104 542 SEK
178 024 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.